시장보고서
상품코드
2104638

바이오인포매틱스용 인공지능 시장 : 구성요소별, 용도별, 최종사용자별, 기술별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2026-2033년)

Artificial Intelligence in Bioinformatics Market, By Component, By Application, By End User, By Technology, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 299 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 4,672,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,560 금액 안내 화살표 ₩ 6,556,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 8,123,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이오인포매틱스용 인공지능(AI) 시장 규모는 2025년에 37억 8,050만 달러로 평가되었으며, 2026년부터 2033년까지 CAGR 24.6%로 확대될 것으로 전망됩니다.

바이오정보학 분야의 AI란, 유전체 연구의 가속화, 단백질 모델링의 예측 정확도 향상, 그리고 의약품 및 맞춤형 치료법 개발을 목적으로 생물학적 정보를 분석하기 위해 기계 학습, 딥러닝, 자연어 처리 등 다양한 인공지능 기술을 활용하는 것을 의미합니다. AI를 활용한 바이오인포매틱스 시스템을 통해 기존 분석 기법보다 훨씬 효율적으로 방대한 양의 임상 정보, 유전체 정보, 단백질체학 정보, 트랜스크립토믹스 정보를 수집하고 분석할 수 있게 됩니다. AI 바이오정보학 시스템의 인기가 높아지는 것은 유전체 연구에 대한 투자뿐만 아니라, 신약 개발에 활용되는 솔루션에 대한 수요가 끊임없이 증가하고 있는 것과 관련이 있습니다. 또한, 이러한 기술을 활용하는 교육 기관, 생명공학 기업, 제약 기업 간의 효과적인 협력은 의료 진단 및 바이오마커 개발, 그리고 맞춤형 치료의 창출을 촉진할 것입니다.

바이오인포매틱스용 인공지능의 시장 역학

유전체 연구 및 AI를 활용한 신약 개발에 대한 투자 확대가 시장 성장을 가속화

차세대 염기서열 분석(NGS), 오믹스 과학, 정밀 의학을 통해 생성되는 생물학적 데이터의 증가는 바이오인포매틱스용 인공지능 도입을 크게 촉진하고 있습니다. 유전체, 단백질체학 및 임상 데이터의 양과 복잡성이 증가함에 따라, 데이터를 적절히 관리하기 위해 연구 기관과 제약 기업 사이에서 AI를 활용한 분석 도구의 사용이 점점 더 보편화되고 있습니다. 이러한 도구는 기계 학습 및 딥러닝 알고리즘을 활용하여 질병 마커 탐지, 단백질 구조 예측, 유전체 변이 규명, 신약 개발 과정 및 기타 업무의 효율화에 기여하고 있습니다. 또한, 만성 질환의 증가와 맞춤형 의료의 보급에 따라 임상 연구 및 진단 분야에서 바이오정보학을 위한 AI 기반 솔루션의 도입이 진행되고 있습니다. 아울러 만성 질환의 증가와 현재의 맞춤형 의료 동향으로 인해 의료 전문가들은 AI 기반 바이오정보학 도입으로 전환하고 있습니다.

예를 들어, 미국 국립보건원(NIH)은 ‘All of Us’ 연구 프로그램이 사상 최대 규모의 데이터세트를 공개했다고 발표했습니다. 이 데이터세트는 74만 7,000명 이상의 데이터로 구성되어 있으며, 유전체 데이터와 전자건강기록(EHR) 데이터를 통합한 세계 최대 규모의 데이터베이스 중 하나입니다. 이 공개 데이터에는 53만 5,000건 이상의 전체 유전체 염기서열과 약 48만 2,000건의 전자건강기록이 연계되어 있어, 생의학 연구에 있어 전례 없는 규모의 유전체 및 임상 정보를 제공하고 있습니다. 이 프로그램은 최첨단 생물정보학, 유전체 시퀀싱 및 AI 기반 분석 기술을 활용하여 정밀 의료 연구의 속도를 높이는 동시에, 질병 위험 및 치료 반응에 대한 이해를 심화하는 것을 목표로 하고 있습니다. 이러한 대규모 프로젝트에서는 복잡한 생의학 데이터를 처리하고 의료 분야의 차세대 연구를 촉진하는 AI 기반 생물정보학 플랫폼 개발에 대한 정부의 자금 지원이 필수적입니다. 이러한 대규모 노력을 배경으로, 생의학 데이터의 복잡성을 효율적으로 관리할 수 있는 AI 기반 생물정보학 플랫폼의 필요성이 제기되고 있습니다.

바이오인포매틱스용 인공지능 시장 : 부문별 분석

전 세계 바이오인포매틱스용 인공지능 시장은 구성요소, 용도, 최종사용자, 기술 및 지역을 기준으로 세분화되어 있습니다.

용도 측면에서 볼 때, 신약 개발 분야가 바이오인포매틱스용 인공지능 시장을 주도하고 있습니다. 이는 표적 식별, 분자 모델링, 화합물 스크리닝, 바이오마커 식별 및 임상시험 최적화를 목적으로 한 AI 알고리즘의 채택이 증가하고 있기 때문입니다. 인공지능 기반 바이오정보학 기술의 활용을 통해 제약 업계 기업들은 방대한 양의 유전체 및 단백질체 데이터를 손쉽게 처리하고 신약 개발 과정을 가속화할 수 있게 되었습니다. 제약 업계, 특히 맞춤형 의료, 바이오의약품, 유전자 치료 시장에서 이러한 솔루션의 도입 확대가 시장을 견인하고 있습니다. 제약 연구, 특히 맞춤형 의료, 바이오의약품, 유전자 치료 시장에서 이러한 서비스의 이용 확대 또한 시장 촉진요인 중 하나입니다. 예를 들어, 2024년 5월, NVIDIA는 IQVIA와 제휴하여 NVIDIA의 기술과 IQVIA의 의료 데이터 및 분석을 활용해 신약 개발 및 임상 개발을 위한 AI 기반 솔루션을 개발했습니다.

기술 측면에서는 기계 학습(ML)이 여전히 시장을 주도하고 있습니다. 이는 유전체, 전사체 및 단백질체 데이터에 숨겨진 패턴을 발견하여 질병의 정확한 예측, 돌연변이 분류 및 정밀 의료 연구로 이어지기 때문입니다. 예를 들어, 미국 국립인간유전체연구소(NHGRI)에서는 대규모 유전체 시퀀싱 프로젝트를 통해 생성된 유전체 데이터를 분석하기 위해 질병 유전자 규명, 기능 유전체학, 정밀 의학 연구 등 폭넓은 분야에서 기계 학습의 활용이 확대되고 있습니다. 생물 의학 연구에서 기계 학습 알고리즘의 활용이 계속 확대됨에 따라, 전 세계적으로 AI 기반 바이오정보학 솔루션의 보급이 더욱 가속화될 것으로 예상됩니다.

바이오인포매틱스용 인공지능 시장 - 지역별 분석

북미는 첨단 생명공학 인프라, 제약 연구, 유전체 시퀀싱 및 생명과학 산업 내 AI 애플리케이션에 대한 막대한 투자가 이루어지고 있어, 바이오인포매틱스용 인공지능 시장에서 가장 큰 시장 점유율을 차지하는 주요 지역입니다. 유전체 정보 분석, 바이오마커 발견, 정밀 의료 수립, 신약 개발을 위한 AI 기반 바이오정보학 도구에 대한 수요가 증가함에 따라 이 시장은 지속적인 성장을 이어가고 있습니다. 미국 국립생물공학정보센터(NCBI)는 미국 국립보건원(NIH) 산하 미국 국립의학도서관(NLM)의 한 부서로서, GenBank, BLAST, SRA 등 다양한 무료 생물정보학 데이터베이스와 도구를 제공하고 있습니다. 이러한 도구와 데이터베이스는 AI를 활용한 유전체 데이터 분석, 서열 분석, 계산 생물학 연구를 위해 전 세계 과학자 커뮤니티에서 널리 활용되고 있습니다. 정부의 지원을 받아 생물학적 데이터베이스는 생물학적 데이터의 광범위한 분석에 활용되고 있으며, 북미의 연구 기관, 제약 회사, 의료 기관에서 AI 기반 바이오정보학 솔루션 도입에 중요한 역할을 해왔습니다.

유럽 역시 주요 시장으로, 유전체학, 맞춤형 의료, 생의학 데이터 분석에 대한 투자가 증가하고 있는 것이 특징이며, 공동 연구 프로젝트와 디지털 헬스 프로그램이 중요한 역할을 하고 있습니다. 학계, 제약 업계, 의료 분야에서 이 지역은 질병 연구의 향상과 치료법의 신속한 발전을 목표로 AI를 접목한 바이오인포매틱스 솔루션의 활용이 확대되고 있습니다. 예를 들어, 유럽분자생물학연구소(EMBL)의 일부인 유럽바이오정보학연구소(EBI)는 오픈 액세스형 생물학적 데이터베이스, AI와 호환되는 바이오정보학 도구, 그리고 유럽 내 단백질 및 유전체학 관련 데이터 통합 및 조사를 위한 고도의 계산 능력을 제공하고 있습니다. 이러한 모든 노력은 유럽 내 AI 기술을 활용한 바이오인포매틱스 플랫폼의 도입에 기여하고 있습니다.

목차

제1장 바이오인포매틱스용 인공지능 시장 개요

제2장 주요 요약

제3장 바이오인포매틱스용 인공지능의 주요 시장 동향

제4장 바이오인포매틱스용 인공지능 시장 : 산업 분석

제5장 바이오인포매틱스용 인공지능 시장 : 높아지는 지정학적 긴장의 영향

제6장 바이오인포매틱스용 인공지능 시장 구도

제7장 바이오인포매틱스용 인공지능 시장 : 구성요소별

제8장 바이오인포매틱스용 인공지능 시장 : 용도별

제9장 바이오인포매틱스용 인공지능 시장 : 최종사용자별

제10장 바이오인포매틱스용 인공지능 시장 : 기술별

제11장 바이오인포매틱스용 인공지능 시장 : 지역별

제12장 주요 벤더 분석 : 바이오인포매틱스용 인공지능 산업

제13장 AnalystView의 전방위적 분석

KSM 26.08.06

Artificial Intelligence in Bioinformatics Market size was valued at US$ 3,780.5 Million in 2025, expanding at a CAGR of 24.6% from 2026 to 2033.

AI in bioinformatics implies the use of different techniques of artificial intelligence like machine learning, deep learning, natural language processing, etc., for the analysis of biological information for the purpose of speeding up genomics studies, improving predictions in protein modeling, and developing drugs and personalized therapies. Bioinformatics systems with the use of AI enable the collection and analysis of vast quantities of clinical, genomic, proteomic, and transcriptomic information much more effectively than conventional analyses. The growing popularity of AI bioinformatics systems is associated with investments made in genome research as well as an ever-increasing demand for the solutions used in drug development. In addition, the effective collaboration of educational institutions, biotechnology companies, and pharma corporations using the technologies will spur the development of medical diagnostics and markers and the creation of personalized treatments.

Artificial Intelligence in Bioinformatics Market- Market Dynamics

Growing Investments in Genomics Research and AI-Driven Drug Discovery Accelerating Market Growth

The increasing generation of biological data via Next-Generation Sequencing (NGS), omics science, and precision medicine is greatly propelling the adoption of Artificial Intelligence in Bioinformatics. The increasing amount and complexity of genomic, proteomic, and clinical data makes AI-enabled analytical tools increasingly popular among research institutes and pharma companies for proper management of the data. They help detect disease markers using machine learning and deep learning algorithms, predict protein structures, understand genomic variants, streamline the process of drug discovery and other operations. Besides, an increasing occurrence of chronic diseases along with the growing popularity of personalized medicine is increasing the adoption of AI-based solutions for bioinformatics in clinical research and diagnostics. Additionally, the increasing occurrences of chronic diseases, as well as the current trend of personalized medicine, make healthcare specialists move to the adoption of AI-based bioinformatics.

For instance, the United States National Institutes of Health (NIH) released a statement saying that the All of Us Research Program had made available the biggest data set to date, which consists of data of over 747,000 people and is among the world's biggest databases containing integrated genomic and electronic health record (EHR) data. The release contained more than 535,000 whole genome sequences paired with almost 482,000 electronic health records, providing an unprecedented amount of genomic and clinical information for biomedical research. The program will use cutting-edge bioinformatics, genomics sequencing and AI-powered analytical techniques to enhance the speed of precision medicine research and understanding of disease risk and response to treatment. These massive projects rely on the government to fund the development of AI-driven bioinformatics platforms that handle intricate biomedical data and facilitate next-generation research in healthcare. The need for AI-driven bioinformatics platforms that efficiently manage the complexities of biomedical data has been raised in the context of such large-scale initiatives.

Artificial Intelligence in Bioinformatics Market- Segmentation Analysis:

The Global Artificial Intelligence in Bioinformatics Market is segmented on the basis of Component, Application, End User, Technology, and Region.

From an application perspective, Drug Discovery & Development is dominating the Artificial Intelligence in Bioinformatics Market because of increasing adoption of AI algorithms for the purposes of target identification, molecular modeling, compound screening, biomarker identification, and optimization of clinical trials. Thanks to the use of bioinformatics technology based on Artificial Intelligence, companies working in the pharmaceutical industry are able to easily deal with massive amounts of genomic and proteomic data and facilitate the drug discovery process. The increasing adoption of these solutions within the pharmaceutical industry, particularly within the personalized medicine, biologics, and gene therapies markets, is driving the market. Increasing utilization of these services in pharmaceutical research, specifically in the personalized medicine, biologics and gene-based therapy markets, is yet another important market driver. For Example, in May 2024, NVIDIA partnered with IQVIA for the development of AI-based solutions for drug discovery and clinical development, using the technology of NVIDIA as well as healthcare data and analytics from IQVIA.

With Technology, Machine Learning (ML) is still leading the market as it discovers the hidden patterns in genomic, transcriptomic and proteomic data, which lead to accurate prediction of disease, variant classification and precision medicine research. For example, the National Human Genome Research Institute (NHGRI) is seeing the growing use of machine learning to analyze genome data produced by large-scale genome sequencing projects, in a range of disease gene identification, functional genomics and precision medicine research applications. As machine learning algorithms continue to be used more in biomedical research, their widespread adoption of AI-based bioinformatics solutions around the globe is likely to be further propelled.

Artificial Intelligence in Bioinformatics Market- Geographical Insights

North America is the major region holds largest market share in the Artificial Intelligence in Bioinformatics Market, due to the presence of advanced biotechnology infrastructure, pharmaceutical research, genome sequencing, and substantial investments in AI applications in the life sciences industry. With the rising requirement of AI-enabled bioinformatics tools for analyzing genomic information, finding biomarkers, formulating precision medicines and drug discovery, this market is growing. The National Center for Biotechnology Information (NCBI) is a component of the National Library of Medicine (NLM) at the National Institutes of Health (NIH) and offers various free bioinformatics databases and tools including GenBank, BLAST, and SRA. These tools and databases are being widely used across the world by the scientific community for genomic data analysis, sequence analysis and computational biology research through the use of AI. With the support of the government, the biological databases are being used for extensive analysis of biological data and have been instrumental in adopting AI-based bioinformatics solutions across research institutes, pharmaceutical companies and healthcare organizations in North America.

Europe is also a major market, marked by rising investments in genomics, personalized medicine and biomedical data analytics, with collaborative research projects and digital health programs playing a key part. In the academic world, pharmaceutical and healthcare sectors, the region is seeing increasing application of AI-infused bioinformatics solutions for better disease research and faster therapeutic advancements. For instance, the European Bioinformatics Institute (EBI), which is part of the European Molecular Biology Laboratory (EMBL), provides open access biological databases, bioinformatics tools compatible with AI, and advanced computational capabilities for data integration and research on proteins and genomics in Europe. All these initiatives are contributing to the adoption of bioinformatics platforms using AI technology in Europe.

Artificial Intelligence in Bioinformatics Market- Competitive Landscape:

The Artificial Intelligence in Bioinformatics Market is highly competitive, wherein the leading biotech and healthcare technologies, cloud computing analytics, and AI companies are aggressively involved in offering their AI-enabled solutions in the bioinformatics industry. Leading organizations in the market include Illumina, Inc., NVIDIA Corporation, Thermo Fisher Scientific Inc., QIAGEN N.V., IBM Corporation, Microsoft Corporation, Google LLC, Oracle Corporation, SOPHiA GENETICS, DNAnexus, Tempus AI, BenevolentAI, Insilico Medicine, BioSymetrics Inc., and Deep Genomics. To gain a competitive edge, firms are spending on AI-enabled genomic analysis tools, protein structure prediction tools, drug discovery software, and precision medicine solutions. Strategic partnerships and product innovations, acquisitions and cloud-based bioinformatics have enabled organizations to accelerate biomedical research, improve clinical decision-making and enable the analysis of large-scale bioinformatics and multi-omics data.

Recent Developments:

In February 2026, The U.S. Department of Agriculture's Animal and Plant Health Inspection Service has awarded Utah State University a $1.9 million contract to create new treatments, drugs and therapies for avian influenza. Associate Professor Rakesh Kaundal led the project using approaches of AI, machine learning and advanced bioinformatics.

In April 2025, Tempus AI entered into new multiyear strategic partnerships with AstraZeneca and Pathos AI for a multimodal foundation model in oncology. The partnership took advantage of Tempus' de-identified oncology information to provide biological and clinical insights, drug discovery and therapeutic development. Included in the agreements were $200 million in data licensing and model development fees.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • NVIDIA Corporation
  • QIAGEN N.V.
  • IBM Corporation
  • Microsoft Corporation
  • Google LLC
  • Oracle Corporation
  • SOPHiA GENETICS SA
  • DNAnexus, Inc.
  • Tempus AI, Inc.
  • BenevolentAI Limited
  • Insilico Medicine
  • Deep Genomics Inc.
  • BioSymetrics Inc.
  • Recursion Pharmaceuticals, Inc.
  • Schrodinger, Inc.
  • BenchSci
  • Atomwise, Inc.
  • PerkinElmer Inc. (Revvity)
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Owkin, Inc.
  • PathAI, Inc.
  • BioAge Labs, Inc.
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033

  • Hardware
  • Software
  • Cloud-Based
  • On-Premise
  • Services

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Drug Discovery and Development
  • Genomics and Gene Sequencing Analysis
  • Proteomics and Protein Structure Prediction
  • Precision Medicine
  • Clinical Diagnostics and Disease Diagnosis
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Hospitals and Healthcare Providers
  • Contract Research Organizations (CROs)
  • Diagnostic Laboratories
  • Government and Public Health Organizations

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Machine Learning (ML)
  • Deep Learning
  • Natural Language Processing (NLP)
  • Computer Vision
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN BIOINFORMATICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Artificial Intelligence in Bioinformatics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. Artificial Intelligence in Bioinformatics Key Market Trends

  • 3.1. Artificial Intelligence in Bioinformatics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Artificial Intelligence in Bioinformatics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Artificial Intelligence in Bioinformatics Market Opportunities
  • 3.4. Artificial Intelligence in Bioinformatics Market Future Trends

4. Artificial Intelligence in Bioinformatics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Bioinformatics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Artificial Intelligence in Bioinformatics Market Landscape

  • 6.1. Artificial Intelligence in Bioinformatics Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Bioinformatics Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
    • 7.1.2. Hardware
    • 7.1.3. Software
      • 7.1.3.1. Cloud-Based
      • 7.1.3.2. On-Premise
    • 7.1.4. Services

8. Artificial Intelligence in Bioinformatics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Drug Discovery and Development
    • 8.1.3. Genomics and Gene Sequencing Analysis
    • 8.1.4. Proteomics and Protein Structure Prediction
    • 8.1.5. Precision Medicine
    • 8.1.6. Clinical Diagnostics and Disease Diagnosis
    • 8.1.7. Others

9. Artificial Intelligence in Bioinformatics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Pharmaceutical and Biotechnology Companies
    • 9.1.3. Academic and Research Institutes
    • 9.1.4. Hospitals and Healthcare Providers
    • 9.1.5. Contract Research Organizations (CROs)
    • 9.1.6. Diagnostic Laboratories
    • 9.1.7. Government and Public Health Organizations

10. Artificial Intelligence in Bioinformatics Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 10.1.2. Machine Learning (ML)
    • 10.1.3. Deep Learning
    • 10.1.4. Natural Language Processing (NLP)
    • 10.1.5. Computer Vision
    • 10.1.6. Others

11. Artificial Intelligence in Bioinformatics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Artificial Intelligence in Bioinformatics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Artificial Intelligence in Bioinformatics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Artificial Intelligence in Bioinformatics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Artificial Intelligence in Bioinformatics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Artificial Intelligence in Bioinformatics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Artificial Intelligence in Bioinformatics Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Illumina, Inc.
    • 12.2.2. Thermo Fisher Scientific Inc.
    • 12.2.3. NVIDIA Corporation
    • 12.2.4. QIAGEN N.V.
    • 12.2.5. IBM Corporation
    • 12.2.6. Microsoft Corporation
    • 12.2.7. Google LLC
    • 12.2.8. Oracle Corporation
    • 12.2.9. SOPHiA GENETICS SA
    • 12.2.10. DNAnexus, Inc.
    • 12.2.11. Tempus AI, Inc.
    • 12.2.12. BenevolentAI Limited
    • 12.2.13. Insilico Medicine
    • 12.2.14. Deep Genomics Inc.
    • 12.2.15. BioSymetrics Inc.
    • 12.2.16. Recursion Pharmaceuticals, Inc.
    • 12.2.17. Schrodinger, Inc.
    • 12.2.18. BenchSci
    • 12.2.19. Atomwise, Inc.
    • 12.2.20. PerkinElmer Inc. (Revvity)
    • 12.2.21. Agilent Technologies, Inc.
    • 12.2.22. F. Hoffmann-La Roche Ltd.
    • 12.2.23. Siemens Healthineers AG
    • 12.2.24. Owkin, Inc.
    • 12.2.25. PathAI, Inc.
    • 12.2.26. BioAge Labs, Inc.
    • 12.2.27. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기